Title Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib
Authors Qin, Ya-Zhen
Jiang, Qian
Lai, Yue-Yun
Jiang, Hao
Shi, Hong-Xia
Zhao, Xiao-Su
Liu, Yan-Rong
Huang, Xiao-Jun
Affiliation Peking Univ, Peking Univ Peoples Hosp, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China.
Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.
11 Xizhimen South St, Beijing, Peoples R China.
Keywords Chronic myeloid leukemia
imatinib
molecular response
cytogenetic response
molecular response of 4.5 (MR4.5)
TYROSINE KINASE INHIBITORS
TREATMENT-FREE REMISSION
ABL TRANSCRIPT LEVELS
CML-STUDY IV
CHRONIC-PHASE
BCR-ABL
CHROMOSOMAL-ABNORMALITIES
NILOTINIB
BCR-ABL1
OUTCOMES
Issue Date 2017
Publisher LEUKEMIA & LYMPHOMA
Citation LEUKEMIA & LYMPHOMA.2017,58(6),1384-1393.
Abstract To investigate the impact of the combination of early molecular and cytogenetic responses on the achievement of MR4.5, 228 newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib were categorized into 3-month and 6-month concordant optimal, discordant, concordant warning, and failure groups. Among them, 85.3% at 3 months and 78.1% at 6 months had concordant molecularly and cytogenetically defined responses. At both 3 and 6 months, patients with discordant, concordant warning and failure responses had similar 3-year MR4.5 rates, and all were significantly lower than the rate in patients with concordant optimal responses. Patients with concurrent 3-month and 6-month concordant optimal responses had a significantly higher 3-year MR4.5 rate than those with other responses, and 3-month and 6-month concurrent molecular optimal, but not cytogenetic optimal responses. Therefore, achieving concordant optimal molecular and cytogenetic responses at both 3 and 6 months with imatinib treatment are associated with MR4.5 achievement.
URI http://hdl.handle.net/20.500.11897/457454
ISSN 1042-8194
DOI 10.1080/10428194.2016.1239260
Indexed SCI(E)
PubMed
Appears in Collections: 人民医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.